1100023I leidos; to X19 RDB--1: universal influenza IGY antibodies for therapeutic applications
Ended Awarded
- Contract number
- HHSN27200019
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $36,591
Award facts
- Contract value 100% obligated
- $36,591.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN27200019?
HHSN27200019 was awarded to Leidos, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on September 9, 2015.
How much is contract HHSN27200019 worth?
The government has obligated $36,591 on HHSN27200019.
Is contract HHSN27200019 an order under another contract?
Yes. HHSN27200019 is a delivery order under HHSN272201100023I, an indefinite delivery contract.
Was contract HHSN27200019 competed?
The extent of competition for HHSN27200019 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award